Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 23, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Neuroendocrine Tumors
Interventions
DRUG

[99mTc]Tc-TECANT1

only one arm - the administration of \[99mTC\]-Tc-TECANT1 in all patients included

Trial Locations (3)

Unknown

Innsbruck Medical University Department of Nuclear Medicine, Innsbruck

University Medical Centre Ljubljana Department of Nuclear Medicine, Ljubljana

30-688

Department of Endocrinology, Jagiellonian University Medical College, Krakow

All Listed Sponsors
collaborator

Medical University Innsbruck

OTHER

collaborator

NCBJ Polatom: Narodowe Centrum Badań Jądrowych Polatom

INDUSTRY

collaborator

University of Ljubljana

OTHER

collaborator

University Medical Centre Ljubljana

OTHER

lead

Jagiellonian University

OTHER